Formulation and publication of the Third Medium-Term Management Plan
First written in FY2018. 3 of 7 entries say "Advanced", first in FY2020. Latest entry: FY2023.
No other company in this theme has enough history to compare yet.
- FY2023Final-year review and exceeding key performance targetsAnnual report
「Progress in fiscal 2023, the final year of the Third Medium-Term Management Plan, was as follows. Business profit reached ¥312,553 million, up 78.7% year on year, as a result of higher-than-expected revenue growth and appropriate control of selling, general and administrative expenses. This significantly exceeded the Third Medium-Term Management Plan's performance target of business profit growth at an average annual rate of at least 10%, achieving a high level of more than 20% annually.」
The final year of the Third Medium-Term Management Plan significantly exceeded the business profit growth target. However, ROE was 5.3%, and it was not stated that all plan items had been achieved uniformly. - FY2022AdvancedAnnual report
「Progress in fiscal 2022, the fourth year of the Third Medium-Term Management Plan, was as follows.」
In the fourth year of the Third Medium-Term Management Plan, revenue was ¥1,737,998 million, business profit was ¥174,917 million, and ROE was 6.3%, among other results. - FY2021AdvancedAnnual report
「Progress in fiscal 2021, the third year of the Third Medium-Term Management Plan, was as follows.」
In the third year of the Third Medium-Term Management Plan, revenue reached 99.9% of the plan, business profit before investment in R&D expenses reached 99.8%, and business profit reached 98.2%. - FY2020AdvancedAnnual report
「Progress in fiscal 2020, the second year of the Third Medium-Term Management Plan, was as follows.」
In the second year of the Third Medium-Term Management Plan, revenue increased 1.9% year on year, business profit increased 15.9%, and ROE was 8.2%, providing a concrete indication of progress toward the plan's targets. - FY2019AchievedAnnual report
「The Third Medium-Term Management Plan is positioned as “Leaping Forward Globally as a Unique Total Healthcare Company: Five Years of Growth.” With the healthcare-related business and nutraceuticals-related business as its core businesses, we will work to create new value and maximize the value of existing businesses.」
The Third Medium-Term Management Plan was announced on 30 May 2019 and launched as a five-year plan. It set out a specific framework centered on the healthcare-related business and nutraceuticals-related business as core businesses. - FY2019-Q1RestatedAnnual report
「Under the Third Medium-Term Management Plan, for which the current consolidated fiscal year is the first year and which was scheduled to be announced on 30 May 2019,」
The company reiterated that it planned to announce the Third Medium-Term Management Plan on 30 May 2019. - FY2018First statedAnnual report
「We are currently formulating the Third Medium-Term Management Plan and plan to announce it on 30 May 2019.」
Following its review of the Second Medium-Term Management Plan, the company was formulating the Third Medium-Term Management Plan and first explicitly stated that it planned to announce it on 30 May 2019.